International Journal of Cancer Management

Published by: Kowsar

Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients

Mojtaba Vand Rajabpour 1 , Hossein Yahyazadeh ORCID 1 , * and Marzie Beheshti ORCID 1
Authors Information
1 Clinical Cancer Research Center, Milad General Hospital, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: April 2017, 10 (4); e6260
  • Published Online: March 20, 2017
  • Article Type: Research Article
  • Received: April 7, 2016
  • Revised: May 14, 2016
  • Accepted: March 12, 2017
  • DOI: 10.5812/ijcm.6260

How to Cite: Vand Rajabpour M, Yahyazadeh H, Beheshti M. Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients, Int J Cancer Manag. 2017 ; 10(4):e6260. doi: 10.5812/ijcm.6260.

Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Schwartzbaum JA, Fisher JL, Aldape KD, Wrensch M. Epidemiology and molecular pathology of glioma. Nat Clin Pract Neurol. 2006; 2(9) : 494 -503 [DOI][PubMed]
  • 2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10) : 987 -96 [DOI][PubMed]
  • 3. Quick A, Patel D, Hadziahmetovic M, Chakravarti A, Mehta M. Current therapeutic paradigms in glioblastoma. Rev Recent Clin Trials. 2010; 5(1) : 14 -27 [DOI][PubMed]
  • 4. Li SW, Qiu XG, Chen BS, Zhang W, Ren H, Wang ZC, et al. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Chin Med J (Engl). 2009; 122(11) : 1245 -9 [PubMed]
  • 5. Albert FK, Forsting M, Sartor K, Adams HP, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery. 1994; 34(1) : 45 -60 [PubMed]
  • 6. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95(2) : 190 -8 [DOI][PubMed]
  • 7. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004; 6(3) : 227 -35 [DOI][PubMed]
  • 8. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, et al. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand. 2010; 122(3) : 159 -67 [DOI][PubMed]
  • 9. Ahmadloo N, Kani AA, Mohammadianpanah M, Nasrolahi H, Omidvari S, Mosalaei A, et al. Treatment outcome and prognostic factors of adult glioblastoma multiforme. J Egypt Natl Canc Inst. 2013; 25(1) : 21 -30 [DOI][PubMed]
  • 10. Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol. 2006; 24(16) : 2563 -9 [DOI][PubMed]
  • 11. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, et al. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol. 1999; 46(2) : 183 -8 [DOI][PubMed]
  • 12. Kumar N, Kumar P, Angurana SL, Khosla D, Mukherjee KK, Aggarwal R, et al. Evaluation of outcome and prognostic factors in patients of glioblastoma multiforme: A single institution experience. J Neurosci Rural Pract. 2013; 4 -55 [DOI][PubMed]
  • 13. EkİCİ MA, Bulut T, Tucer B, BaŞArslan SK, Kurtsoy A. Prognostic factors in patients with glioblastoma multiforme (clinical research). Turkish J Med Sci. 2013; 43 : 795 -804 [DOI]
  • 14. McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer. 2003; 98(8) : 1745 -8 [DOI][PubMed]
  • 15. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE. Neurological outcome of long-term glioblastoma survivors. J Neurooncol. 2009; 95(3) : 301 -5 [DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments